Satisfaction and persistence with vibegron in the first 6 months of overactive bladder treatment: interim results of the phase 4, real-world COMPOSUR study

Satisfaction and persistence with vibegron in the first 6 months of overactive bladder treatment: interim results of the phase 4, real-world COMPOSUR study

Abstract Background The COMPOSUR study is evaluating vibegron for the treatment of overactive bladder (OAB) in a real-world setting. We report results of a prespecified 6-month interim analysis, assessing patient-reported treatment satisfaction, persistence, safety, and tolerability over the first 6...

Full description

Saved in:
Bibliographic Details
Main Authors: Roger R. Dmochowski, Eric S. Rovner, Michael J. Kennelly, Diane K. Newman, Keith Xavier, Elizabeth Thomas, Daniel Snyder, Laleh Abedinzadeh
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Urology
Subjects:
Adherence
Adrenergic beta-3 receptor agonist
Anticholinergic
Antimuscarinic
Medication persistence
Micturition
Online Access:https://doi.org/10.1186/s12894-025-01742-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12894-025-01742-6

Similar Items